De novo osteogenic sarcoma in patients older than forty: Benefit of multimodality therapy

Clinical Orthopaedics and Related Research

Volumn 438, Issue , 2005, Pages 110-115

  Manoso, Mark W ^a   Healey, John H ^a   Boland, Patrick J ^a   Athanasian, Edward A ^a   Maki, Robert G ^a   Huvos, Andrew G ^a   Morris, Carol D ^a,b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; VINCRISTINE;

ADULT; AGE DISTRIBUTION; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HUMAN; KIDNEY FAILURE; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; OSTEOSARCOMA; PRIORITY JOURNAL; PROGNOSIS; SIDE EFFECT; SURVIVAL RATE; SURVIVAL TIME; TUMOR VOLUME; AGE; ARTICLE; BONE TUMOR; EVIDENCE BASED MEDICINE; LUNG TUMOR; METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; RETROSPECTIVE STUDY; TUMOR RECURRENCE;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BONE NEOPLASMS; COMBINED MODALITY THERAPY; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; OSTEOSARCOMA; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 24344450593     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/01.blo.0000179587.42350.4d     Document Type: Conference Paper

References (24)

1. August M, Magennis P, Dewitt D: Osteogenic sarcoma of the jaws: Factors influencing prognosis. Int J Oral Maxillofac Surg 26:198-204, 1997.
2. Bacci G, Ferrari S, Donati D, et al: Neoadjuvant chemotherapy for osteosarcoma of the extremity in patients in the fourth and fifth decade of life. Oncol Rep 5:1259-1263, 1998.
3. Bacci G, Mercuri M, Briccoli A, et al: Osteogenic sarcoma of the extremity with detectable lung metastasis at presentation: Results of treatment of 23 patients with chemotherapy followed by simultaneous resection of primary and metastatic lesions. Cancer 79:245-254, 1997.
4. Carsi B, Rock M: Primary osteosarcoma in adults older than 40 years. Clin Orthop Relat Res 397:53-61, 2002.
5. Delepine N, Delepine G, Bacci G, Rosen G, Desbois J: Influence of methotrexate dose intensity on outcome of patients with high grade osteogenic sarcoma: Analysis of literature. Cancer 78:2127-2135, 1996.
6. Duffaud F, Digue L, Mercier C, et al: Recurrences following primary osteosarcoma in adolescents and adults previously treated with chemotherapy. Eur J Cancer 39:2050-2057, 2003.
7. Enneking W, Spanier S, Goodman M: A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop Relat Res 153:106-120, 1980.
8. Glasser D, Lane J, Huvos A, Marcove R, Rosen G: Survival, prognosis and therapeutic response in osteogenic sarcoma. Cancer 69:698-708, 1992.
9. Greene F, Page D, Fleming I, et al: Cancer staging handbook. From the AJCC Cancer Staging Manual. Ed 6. New York, Springer 213-219, 2002.
10. Grimer R, Cannon SR, Taminiau AHM, et al: Osteosarcoma over the age of forty. Eur J Cancer 39:157-163, 2003.
11. Hawkins D, Arndt C: Pattern of disease recurrence and prognostic factors in patients with osteosarcoma treated with contemporary chemotherapy. Cancer 98:2447-2456, 2003.
12. Huvos A: Osteogenic sarcoma of bones and soft tissues in older persons: A clinicopathological analysis of 117 patients older than 60 years. Cancer 57:1442-1449, 1986.
13. Huvos A, Rosen G, Marcove R: Primary osteogenic sarcoma: Pathologic aspects in 20 patients after treatment with chemotherapy en bloc resection and prosthetic bone replacement. Arch Pathol Lab Med 101:14-18, 1977.
14. Kager L, Zoubek A, Pötschger U, et al: Primary metastatic osteosarcoma: Presentation and outcome of patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol 21:2011-2018, 2003.
15. Kaplan E, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958.
16. Meyers P, Heller G, Healey J, et al: Osteogenic sarcoma with clinically detectable metastasis at initial presentation. J Clin Oncol 11:449-453, 1993.
17. Meyers P, Heller G, Healey J, et al: Chemotherapy for nonmetastatic osteogenic sarcoma: The Memorial Sloan-Kettering experience. J Clin Oncol 10:5-15, 1992.
18. Nagler R, Malkin L, Ben-Arieh Y, Laufer D: Sarcoma of the maxillofacial region: Follow-up of 25 cases. Anticancer Res 20:3735-3741, 2000.
19. Patel S, Meyers P, Huvos AG, et al: Improved outcomes in patients with osteogenic sarcoma of the head and neck. Cancer 95:1495-1503, 2002.
20. Rosen G, Caparros B, Huvos AG, et al: Preoperative chemotherapy for osteogenic sarcoma: Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer 49:1221-1230, 1982.
21. Scully S, Temple H, O'Keefe R, Mankin H, Gebhardt M: The surgical treatment of patients with osteosarcoma who sustain a pathologic fracture. Clin Orthop Relat Res 324:227-232, 1996.
22. Su WT, Chewning J, Abramson S, et al: Surgical management and outcomes of osteosarcoma patients with unilateral pulmonary metastases. J Pediatr Surg 39:418-422, 2004.
23. Winkler K, Beron G, Delling G, et al: Neoadjuvant chemotherapy of osteosarcoma: Results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumour response. J Clin Oncol 6:329-337, 1988.
24. Winkler K, Beron G, Kotz R, et al: Neoadjuvant chemotherapy for osteogenic sarcoma: Results of a Cooperative German/Austrian study. J Clin Oncol 2:617-624, 1984.